| Literature DB >> 27267586 |
Lennart Wiehe1, Malte Cremer2, Monika Wisniewska1, Niels-Peter Becker1, Eddy Rijntjes1, Janine Martitz1, Sandra Hybsier1, Kostja Renko1, Christoph Bührer2, Lutz Schomburg1.
Abstract
Infectious diseases impair Se metabolism, and low Se status is associated with mortality risk in adults with critical disease. The Se status of neonates is poorly characterised, and a potential impact of connatal infection is unknown. We hypothesised that an infection negatively affects the Se status of neonates. We conducted an observational case-control study at three intensive care units at the Charité-Universitätsmedizin Berlin, Germany. Plasma samples were collected from forty-four neonates. On the basis of clinical signs for bacterial infection and concentrations of IL-6 or C-reactive protein, neonates were classified into control (n 23) and infected (n 21) groups. Plasma Se and selenoprotein P (SePP) concentrations were determined by X-ray fluorescence and ELISA, respectively, at day of birth (day 1) and 48 h later (day 3). Se and SePP showed a positive correlation in both groups of neonates. Se concentrations indicative of Se deficit in adults (500 ng/l). During antibiotic therapy, SePP increased significantly from day 1 (1·03 (sd 0·10) mg/l) to day 3 (1·34 (sd 0·10) mg/l), indicative of improved hepatic Se metabolism. We conclude that both Se and SePP are suitable biomarkers for assessing Se status in neonates and for identifying subjects at risk of deficiency.Entities:
Keywords: CRP C-reactive protein; Gentamicin; IL-6; IQR interquartile range; Intensive care; Micronutrients; SePP selenoprotein P; Selenoproteins
Mesh:
Substances:
Year: 2016 PMID: 27267586 DOI: 10.1017/S0007114516002208
Source DB: PubMed Journal: Br J Nutr ISSN: 0007-1145 Impact factor: 3.718